128 related articles for article (PubMed ID: 3497749)
1. HLA typing data on 100 type 1 (insulin-dependent) diabetic patients from central Italy show a negative association with DR5 rather than with DR2.
Vela M; Adorno D; Longo A; Papola F; Maccarone D; Centis D; Raponi MP; Candela A; Campea L; Orsini M
Clin Immunol Immunopathol; 1987 Oct; 45(1):143-6. PubMed ID: 3497749
[TBL] [Abstract][Full Text] [Related]
2. Inherited susceptibility to insulin-dependent diabetes is associated with HLA-DR1, while DR5 is protective.
Maclaren N; Riley W; Skordis N; Atkinson M; Spillar R; Silverstein J; Klein R; Vadheim C; Rotter J
Autoimmunity; 1988; 1(3):197-205. PubMed ID: 2979618
[TBL] [Abstract][Full Text] [Related]
3. HLA-antigens in Italian type 1 diabetic patients: role of DR3/DR4 antigens and breast feeding in the onset of the disease.
Bognetti E; Meschi F; Malavasi C; Pastore MR; Sergi A; Illeni MT; Maffeis C; Pinelli L; Chiumello G
Acta Diabetol; 1992; 28(3-4):229-32. PubMed ID: 1576360
[TBL] [Abstract][Full Text] [Related]
4. HLA gene and phenotype data of 60 insulin-dependent diabetic patients from north-eastern Italy. A negative association with DR5 rather than DR2?
Maffeis C; Ciaffoni S; Gonfiatini E; Roata C; Pinelli L
Acta Diabetol Lat; 1990; 27(3):223-30. PubMed ID: 2075785
[TBL] [Abstract][Full Text] [Related]
5. Association of HLA-DQw3 (TA10-) with type I diabetes occurs with DR3/4 but not DR1/4 patients.
Tait BD; Mraz G; Harrison LC
Diabetes; 1988 Jul; 37(7):926-9. PubMed ID: 3260201
[TBL] [Abstract][Full Text] [Related]
6. Organ-specific autoimmunity and HLA-DR antigens as markers for beta-cell destruction in patients with type II diabetes.
Groop L; Miettinen A; Groop PH; Meri S; Koskimies S; Bottazzo GF
Diabetes; 1988 Jan; 37(1):99-103. PubMed ID: 3275559
[TBL] [Abstract][Full Text] [Related]
7. HLA A, B, and DR antigens and complotype in Tunisian patients with diabetes mellitus.
Ayed K; Bardi R; Gorgi Y; Jenhani F; Chammakhi S; Boukhris R
Dis Markers; 1989; 7(1):43-7. PubMed ID: 2714046
[TBL] [Abstract][Full Text] [Related]
8. The genetic susceptibility to type 1 (insulin-dependent) diabetes: analysis of the HLA-DR association.
Wolf E; Spencer KM; Cudworth AG
Diabetologia; 1983 Apr; 24(4):224-30. PubMed ID: 6407886
[TBL] [Abstract][Full Text] [Related]
9. [Lyme disease and HLA-DR antigens: relation between HLA-DR2 and HLA-DR4].
Májský A; Bojar M; Jirous J
Vnitr Lek; 1988 Jan; 34(1):54-9. PubMed ID: 3258452
[No Abstract] [Full Text] [Related]
10. Different contribution of class II HLA in fulminant and typical autoimmune type 1 diabetes mellitus.
Imagawa A; Hanafusa T; Uchigata Y; Kanatsuka A; Kawasaki E; Kobayashi T; Shimada A; Shimizu I; Maruyama T; Makino H
Diabetologia; 2005 Feb; 48(2):294-300. PubMed ID: 15688210
[TBL] [Abstract][Full Text] [Related]
11. Polymyalgia rheumatica: a syndrome associated with HLA-DR4 antigen.
Cid MC; Ercilla G; Vilaseca J; Sanmarti R; Villalta J; Ingelmo M; Urbano-Marquez A
Arthritis Rheum; 1988 May; 31(5):678-82. PubMed ID: 3259885
[TBL] [Abstract][Full Text] [Related]
12. [HLA-antigens and islet cell antibodies in type-1 diabetics of various age groups and their first-degree relatives].
Spinas GA; Keller U; Neri TM; Matter L; Staffelbach O; Berger W
Schweiz Med Wochenschr; 1985 Jan; 115(2):48-54. PubMed ID: 3881821
[TBL] [Abstract][Full Text] [Related]
13. Insulin-dependent diabetes--associated HLA-D region encoded determinants.
Bach FH; Rich SS; Barbosa J; Segall M
Hum Immunol; 1985 Feb; 12(2):59-64. PubMed ID: 3871432
[TBL] [Abstract][Full Text] [Related]
14. HLA-DR typing in identical twins with insulin-dependent diabetes: difference between concordant and discordant pairs.
Johnston C; Pyke DA; Cudworth AG; Wolf E
Br Med J (Clin Res Ed); 1983 Jan; 286(6361):253-5. PubMed ID: 6402059
[TBL] [Abstract][Full Text] [Related]
15. Progressive autoimmune beta cell insufficiency: occurrence in the absence of high-risk HLA alleles DR3, DR4.
Eisenbarth GS; Srikanta S; Fleischnick E; Ganda OP; Jackson RA; Brink SJ; Soeldner JS; Yunis EJ; Alper C
Diabetes Care; 1985; 8(5):477-80. PubMed ID: 3876922
[TBL] [Abstract][Full Text] [Related]
16. HLA-DR binding analysis of peptides from islet antigens in IDDM.
Geluk A; van Meijgaarden KE; Schloot NC; Drijfhout JW; Ottenhoff TH; Roep BO
Diabetes; 1998 Oct; 47(10):1594-601. PubMed ID: 9753297
[TBL] [Abstract][Full Text] [Related]
17. Glutamic acid decarboxylase antibodies in relation to other autoantibodies and genetic risk markers in children with newly diagnosed insulin-dependent diabetes. Childhood Diabetes in Finland Study Group.
Sabbah E; Kulmala P; Veijola R; Vähäsalo P; Karjalainen J; Tuomilehto-Wolf E; Akerblom HK; Knip M
J Clin Endocrinol Metab; 1996 Jul; 81(7):2455-9. PubMed ID: 8675560
[TBL] [Abstract][Full Text] [Related]
18. Human lymphocyte antigen DR types in relation to early clinical manifestations in diabetic children.
Ludvigsson J; Lindblom B
Pediatr Res; 1984 Dec; 18(12):1239-41. PubMed ID: 6335238
[TBL] [Abstract][Full Text] [Related]
19. HLA studies of endemic African Kaposi's sarcoma patients and matched controls: no association with HLA-DR5.
Melbye M; Kestens L; Biggar RJ; Schreuder GM; Gigase PL
Int J Cancer; 1987 Feb; 39(2):182-4. PubMed ID: 3492448
[TBL] [Abstract][Full Text] [Related]
20. HLA type and the genetic risk for type 1 diabetes mellitus.
MacMillan DR; Foster MB; Key MP
J Ky Med Assoc; 1991 Jan; 89(1):19-21. PubMed ID: 1995752
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
